Stratum Adds Oral Probiotics to Portfolio
BLIS K12 and BLIS M18 are specific strains of Streptococcus salivarius.
Stratum Nutrition (St. Louis) has formally added oral probiotic strains BLIS K12 and BLIS M18 to its product portfolio. Stratum will exclusively distribute these ingredients for BLIS Technologies Ltd. in the United States, Canada, Europe, and other regions.
BLIS K12 and BLIS M18 are specific strains of Streptococcus salivarius. BLIS K12 supports healthy bacteria in the mouth, promoting fresh breath and immune support. BLIS M18 supports healthy teeth and gums, populating the oral cavity with beneficial bacteria and providing a less hospitable environment for bacteria such as Streptococcus mutans. Additionally, it can produce unique enzymes that may protect against dental plaque and neutralize acid that can be harmful to teeth and gums.
The Nutritional Outlook Podcast Episode 35: Prioritizing Women's Health Research and Innovation
October 28th 2024On this month's episode of the Nutritional Outlook Podcast, Cepham's founder and president, Anand Swaroop, discusses the company's recent announcement to prioritize women's health research and innovation.
The Nutritional Outlook Podcast Episode 34: Demystifying Prebiotics and Postbiotics
September 30th 2024In this episode of the Nutritional Outlook Podcast we are looking back on a webcast Nutritional Outlook hosted in May, called “Demystifying the Prebiotic and Postbiotic Markets.” During that event, Sandra Saville, director of education and communication for the International Probiotics Association and Dr. Jessica A. Younes, scientific director of the International Probiotics Association debunked myths about prebiotic and postbiotics, and defined the respective categories to help manufacturers better understand how to responsibly formulate and market prebiotic and postbiotic products.
